CAM
ONC icon

Cresset Asset Management’s BeOne Medicines Ltd ONC Stock Holding History

Cresset Asset Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,035
Closed -$282K – 1829
2025
Q1 		$282K Buy
+1,035
New +$242K ﹤0.01% 1352
2022
Q1 		– Sell
-1,557
Closed -$423K – 1169
2021
Q4 		$423K Buy
1,557
+270
+21% +$91.2K ﹤0.01% 749
2021
Q3 		$467K Buy
1,287
+382
+42% +$125K 0.01% 649
2021
Q2 		$311K Buy
905
+59
+7% +$19.5K ﹤0.01% 750
2021
Q1 		$295K Buy
+846
New +$280K ﹤0.01% 688

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Cresset Asset Management's ONC Position: Q2 2025 in Review

Cresset Asset Management sold out of BeOne Medicines Ltd (ONC) in Q2 2025, closing a stake of 1,035 shares — an estimated $282K sold.

Cresset Asset Management first reported a position in ONC in Q1 2021 and held it in 5 quarters. The position peaked at $467K in Q3 2021. 245 funds tracked by Wall St. Rank hold ONC as of Q2 2025.

  • Cresset Asset Management reported no remaining BeOne Medicines Ltd position as of Q2 2025 after selling out during the quarter.
  • Cresset Asset Management sold 1,035 BeOne Medicines Ltd shares in Q2 2025, an estimated $282K.
  • Cresset Asset Management first reported a position in BeOne Medicines Ltd in Q1 2021 and held it in 5 quarters.
  • Cresset Asset Management's BeOne Medicines Ltd position peaked at $467K in Q3 2021.
  • 245 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2025.

Based on Cresset Asset Management's 13F filing for Q2 2025, filed 13 Aug 2025.